Isabelle Borghini-Fuhrer
Dados Biográficos
| ID | 9064174 |
|---|---|
| NOME | Isabelle Borghini-Fuhrer |
| PRENOMES | Isabelle |
| SOBRENOME | Borghini-Fuhrer |
| ASSINATURA | BORGHINI-FUHRER I |
| AFILIAÇÕES | Medicines for Malaria Venture |
| VERIFICADO | Não |
| TOTAL DE OBRAS | 2 |
| TOTAL DE CITAÇÕES | 0 |
| TOTAL COMO AUTOR | 2 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2025 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2026 |
| ÍNDICE H | 0 |
Improving malaria chemoprevention coverage in pregnancy
Sulfadoxine-pyrimethamine (SP) is the only WHO-recommended option for the intermittent preventive treatment of malaria in pregnancy (IPTp). However, coverage is suboptimal, efficacy is limited in areas of high resistance and SP is contraindicated in the first trimester and women living with HIV receiving cotrimoxazole. This study investigated stakeholder perspectives on next-generation IPTp product characteristics and their potential impact on up…
Prospective observational study to assess the feasibility and safety of appropriate Plasmodium vivax radical cure with tafenoquine or primaquine after quantitative G6PD testing during pilot implementa…
Introduction Plasmodium vivax recurrence prevention using tafenoquine or primaquine is critical for achieving Thailand’s malaria elimination targets. Both drugs may cause haemolysis in glucose-6-phosphate dehydrogenase (G6PD) deficient individuals. This study evaluated the operational feasibility and safety of administering tafenoquine or primaquine after quantitative G6PD point-of-care testing in Thailand. Methods This prospective, observational…
Sem obras proeminentes nesta página.
Prospective observational study to assess the feasibility and safety of appropriate Plasmodium vivax radical cure with tafenoquine or primaquine after quantitative G6PD testing during pilot implementa…
Introduction Plasmodium vivax recurrence prevention using tafenoquine or primaquine is critical for achieving Thailand’s malaria elimination targets. Both drugs may cause haemolysis in glucose-6-phosphate dehydrogenase (G6PD) deficient individuals. This study evaluated the operational feasibility and safety of administering tafenoquine or primaquine after quantitative G6PD point-of-care testing in Thailand. Methods This prospective, observational…
Improving malaria chemoprevention coverage in pregnancy
Sulfadoxine-pyrimethamine (SP) is the only WHO-recommended option for the intermittent preventive treatment of malaria in pregnancy (IPTp). However, coverage is suboptimal, efficacy is limited in areas of high resistance and SP is contraindicated in the first trimester and women living with HIV receiving cotrimoxazole. This study investigated stakeholder perspectives on next-generation IPTp product characteristics and their potential impact on up…
Malaria (2 obras) · Malaria Research and Control (2 obras) · Chloroquine (1 obras) · Dosing (1 obras) · Global Maternal and Child Health (1 obras) · Immunology (1 obras) · Internal Medicine (1 obras) · Medicine (1 obras) · Methemoglobinemia and Tumor Lysis Syndrome (1 obras) · Neonatal Health and Biochemistry (1 obras)